Federated Hermes, Inc. Immunity Bio, Inc. Transaction History

Federated Hermes, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$3.23 - $6.17 $3 - $6	1 Added 0.51%	198 $1,000
Q4 2023 Jan 31, 2024	SELL	$1.25 - $5.21 $78 - $328	-63 Reduced 24.23%	197 $0
Q3 2023 Nov 13, 2023	SELL	$1.29 - $3.1 $19,988 - $48,034	-15,495 Reduced 98.35%	260 $0
Q2 2023 Aug 14, 2023	SELL	$1.53 - $6.41 $9,565 - $40,075	-6,252 Reduced 28.41%	15,755 $43,000
Q1 2023 May 08, 2023	BUY	$1.35 - $4.78 $29,709 - $105,193	22,007 New	22,007 $40,000
Q2 2022 Aug 15, 2022	SELL	$2.68 - $6.14 $5,354 - $12,267	-1,998 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.05 - $7.53 $15 - $22	3 Added 0.15%	1,998 $11,000
Q4 2021 Feb 14, 2022	SELL	$5.67 - $10.18 $14,339 - $25,745	-2,529 Reduced 55.9%	1,995 $12,000
Q3 2021 Nov 15, 2021	SELL	$9.17 - $14.24 $311 - $484	-34 Reduced 0.75%	4,524 $44,000
Q2 2021 Aug 16, 2021	BUY	$13.41 - $22.4 $59,889 - $100,038	4,466 Added 4854.35%	4,558 $65,000
Q1 2021 May 13, 2021	BUY	$12.83 - $42.25 $1,180 - $3,887	92 New	92 $2,000

204

70M

1.68M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.05B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.